[Combined treatment of palmoplantar syndrome in patients under antitumor therapy].

Autor: Kruglova LS, Shatokhina EA, Elfimov MA, Illarionov VE, Chervinskaya AV, Portnov VV, Filatova EV, Petrova MS
Jazyk: ruština
Zdroj: Meditsina truda i promyshlennaia ekologiia [Med Tr Prom Ekol] 2016 (2), pp. 21-4.
Abstrakt: Observation covered 12 patients under various antitumor medications. Group 1 was formed of patients with developed palmoplantar syndrome varying in severity, who received complex treatment including IR-therapy and local antioxidant medication. Group 2 included patients without palmoplantar syndrome, who received preventive treatment with IR-therapy. All patients of group 1 demonstrated lower severity of palmoplantar syndrome manifestations. In group 2, 80% of the patients avoided palmoplantar syndrome development, and 20% of the patients had light course of the syndrome manifestations. Patients at high risk of palmoplantar syndrome under antitumor therapy are recommended to undergo IR-therapy and local antioxidant medication.
Databáze: MEDLINE